The M.U.S.T. SI Screw System is intended for sacroiliac joint fusion for skeletally mature patients suffering from sacroiliac joint disruption, degenerative sacroiliitis and degenerative sacroiliac arthritis, secondary to pelvic disruption.
The M.U.S.T. SI system features:
- Screws coated with porous and rough hydroxyapatite that are designed with hollow-body and multiple fenestrated patterned shafts to promote biological fixation and optimal arthrodesis.
- The self-tapping screws have radial windowed slots to optimize surrounding bone access to the bone substitute, allowing greater bone growth; a long pitch and dual lead thread for accelerated screw insertion and removal; and a tapered tip to aid in guidance through the pilot hole.
- The system also offers “one-size-fits-all” washers with favored angles, capable of accommodating extreme angulation and allowing optimal compression, as well as a comprehensive range of lengths suited for diverse patient anatomies.
“The M.U.S.T. SI System addresses another area of spine impairment, allowing us to continue enhancing our already comprehensive spine portfolio and build out our offerings that are well suited for both traditional and outpatient settings,” said Francesco Siccardi, executive vice president, Medacta International. “Congratulations to Dr. Sahai and team on a successful surgery; we’re always thrilled to see positive patient outcomes and look forward to rolling out this effective product throughout the U.S.”
M.U.S.T. SI is the newest addition to the M.U.S.T. Screw System portfolio, designed to deliver flexibility and versatility for surgeons. When paired with Medacta’s MectaLIF family of inter-body fusion devices and suite of specialized surgical instruments, the result is a harmonized, single-system approach for most spine stabilization applications.
About Medacta
Medacta is an international company specialized in the design and production of innovative orthopaedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. Established in 1999 in Switzerland, Medacta’s products and surgical techniques are characterized by innovation. Medacta is a pioneer in developing new offerings on the basis of minimally invasive surgical techniques, in particular its Anterior Minimally Invasive Surgery (AMIS) technique for hip replacements. Medacta has leveraged its orthopaedic expertise and comprehensive understanding of the human body to develop the sophisticated MySolutions technology, which offers surgeons highly personalized pre-operative planning and implant placement methodologies by creating advanced personalized kinematic models and 3D planning tools for use in hip, knee, shoulder and spine procedures.